The DOI matches its Crossref record; 94 of the 95 references it cites were found in a registry or an index.
Popular Ergogenic Drugs and Supplements in Young Athletes
Abstract
Ergogenic drugs are substances that are used to enhance athletic performance. These drugs include illicit substances as well as compounds that are marketed as nutritional supplements. Many such drugs have been used widely by professional and elite athletes for several decades. However, in recent years, research indicates that younger athletes are increasingly experimenting with these drugs to improve both appearance and athletic abilities. Ergogenic drugs that are commonly used by youths today include anabolic-androgenic steroids, steroid precursors (androstenedione and dehydroepiandrosterone), growth hormone, creatine, and ephedra alkaloids. Reviewing the literature to date, it is clear that children are exposed to these substances at younger ages than in years past, with use starting as early as middle school. Anabolic steroids and creatine do offer potential gains in body mass and strength but risk adverse effects to multiple organ systems. Steroid precursors, growth hormone, and ephedra alkaloids have not been proven to enhance any athletic measures, whereas they do impart many risks to their users. To combat this drug abuse, there have been recent changes in the legal status of several substances, changes in the rules of youth athletics including drug testing of high school students, and educational initiatives designed for the young athlete. This article summarizes the current literature regarding these ergogenic substances and details their use, effects, risks, and legal standing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While creatine appears to be a popular dietary supplement of choice among elite adolescent athletes, creatine is still less frequently used when compared to other dietary supplement categories such as multivitamins, protein powders, and energy products, in which usage rates of these product categories can range anywhere from 60–80% among adolescent athletes [26,27,28,29,30,31,32].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [30]
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
(2006) · PubMed · Cited by 3,378
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis
Greenhaff, P. L., Bodin, K., Soderlund, K., & Hultman, E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.5.e725 · Cited by 531
Estimated Prevalence of Anabolic Steroid Use Among Male High School Seniors
Buckley, W. E. (1988) · JAMA · doi:10.1001/jama.1988.03410230059028 · Cited by 530
Youth Risk Behavior Surveillance--United States, 2003
Grunbaum, J. A., Kann, L., Kinchen, S., Ross, J., Hawkins, J., & Lowry, R. (2004) · PsycEXTRA Dataset · doi:10.1037/e307132005-001 · Cited by 477
Anabolic steroids: A review of the literature
Haupt, H. A., & Rovere, G. D. (1984) · The American Journal of Sports Medicine · doi:10.1177/036354658401200613 · Cited by 438
Wilson, J. D. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-2-181 · Cited by 427
Research works printed but not linked: 5
- Bamberger M, Yaeger D. Over the edge: special report. Sports Illustrated. 1997;86:64
- Cable NT. Anabolic-androgenic steroids: ergogenic and cardiovascular effects. In: Reilly T, Orme M, eds. The Clinical Pharmacology of Sport and Exercise. Amsterdam, Netherlands: Excerpta Medica; 1997:135–144
- Zorpette G. The mystery of muscle. Sci Am. 1999;10:48–55
- Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 1996:221–224
- New drug status of OTC combination drug products containing caffeine. Phenylpropanolamine and ephedrine. Fed Regist. 1982;47:35;344–355
Cited by
Sorted by citations
Use of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 349
The social-cognitive mechanisms regulating adolescents' use of doping substances
Lucidi, F., Zelli, A., Mallia, L., Grano, C., Russo, P. M., & Violani, C. (2008) · Journal of Sports Sciences · doi:10.1080/02640410701579370 · Cited by 252
A Systematic Review of Self-Medication Practices Among Adolescents
Shehnaz, S. I., Agarwal, A. K., & Khan, N. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.07.001 · Cited by 196
Backhouse, S. H., Whitaker, L., & Petróczi, A. (2011) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2011.01374.x · Cited by 189
Petróczi, A. (2007) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-2-34 · Cited by 153
Metadata
- Authors
- Calfee, R., & Fadale, P.
- Affiliations
- Brown University (US)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-03-01
- Volume
- 117
- Issue
- 3
- Pages
- e577-e589
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2120061101
- Cited by
- 280
- References
- 95
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 5 · 2019: 6 · 2018: 17 · 2017: 15 · 2016: 21 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 25
- FWCI
- 81.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- ergogenic aids, performance-enhancing drugs, youth athletes, anabolic steroids, steroid precursors, androstenedione, dehydroepiandrosterone, growth hormone, creatine, ephedrine alkaloids, adverse effects, health education
- MeSH terms
- Adolescent, Affect, Aggression, Creatine, Dehydroepiandrosterone, Doping in Sports, Ephedrine, Humans, Legislation, Drug, Sports Medicine, Illicit Drugs, United States, Substance Abuse Detection, Human Growth Hormone, Dietary Supplements, Anabolic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review